Sequana Medical NV (FRA:2SE) EPS without NRI: €-1.23 (TTM As of Jun. 2025)


FRA:2SE Sequana Medical NV FRA:2SE
31 GF Score
Price €0.51
GF Value €0.19
! 12 Warning Signs
View Full Analysis

What is Sequana Medical NV EPS without NRI?

Sequana Medical NV FRA:2SE 31 EPS without NRI is €-1.23 as of Jun. 2025. GuruFocus rates FRA:2SE with a GF Score™ of 31/100 and a GF Value™ of €0.19. The stock has 12 warning signs investors should review. Among 662 Medical Devices & Instruments companies, Sequana Medical NV ranks worse than 58.61% on this metric.

Sequana Medical NV's earnings per share without non-recurring items for the six months ended in Jun. 2025 was €-0.35. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2025 was €-1.23.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 2.10% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Sequana Medical NV's EPS without NRI or its related term are showing as below:

FRA:2SE' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -27.6   Med: -6   Max: 2.1
Current: 2.1

During the past 11 years, Sequana Medical NV's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 2.10% per year. The lowest was -27.60% per year. And the median was -6.00% per year.

FRA:2SE's 3-Year EPS without NRI Growth Rate is ranked worse than
58.61% of 662 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs FRA:2SE: 2.10

Sequana Medical NV's EPS (Diluted) for the six months ended in Jun. 2025 was €-0.35. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2025 was €-1.23.

Sequana Medical NV's EPS (Basic) for the six months ended in Jun. 2025 was €-0.35. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2025 was €-1.23.


Sequana Medical NV  (FRA:2SE) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sequana Medical NV EPS without NRI Related Terms


Sequana Medical NV EPS without NRI Historical Data

* Premium members only.

The historical data trend for Sequana Medical NV's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sequana Medical NV EPS without NRI Chart

Sequana Medical NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.25 -1.30 -1.35 -1.22 -1.22

Sequana Medical NV Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.65 -0.57 -0.34 -0.88 -0.35

FRA:2SE vs ABT, SYK, MDT: EPS without NRI Comparison

For the Medical Devices subindustry, Sequana Medical NV's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sequana Medical NV PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Sequana Medical NV's PE Ratio without NRI falls into.


FRA:2SE
31GF Score
Sequana Medical NV FRA:2SE
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sequana Medical NV EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €-1.23 mean?
Sequana Medical NV (FRA:2SE) has a EPS without NRI of €-1.23 as of Jun. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Sequana Medical NV and its competitors. According to the industry distribution chart, Sequana Medical NV ranks #388 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 58.6%.
Is Sequana Medical NV's EPS without NRI too high?
Sequana Medical NV's current EPS without NRI is €-1.23. Based on the distribution chart, Sequana Medical NV ranks #388 out of 662 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sequana Medical NV has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Sequana Medical NV's EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sequana Medical NV ranks #388 out of 662 companies for EPS without NRI. This places Sequana Medical NV in the lower half of its industry. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Sequana Medical NV and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sequana Medical NV's current EPS without NRI is €-1.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sequana Medical NV stock overvalued right now?
Sequana Medical NV (FRA:2SE) has a current EPS without NRI of €-1.23. The stock's GF Value™ is €0.19, compared to a current price of €0.51 — trading 169.5% above its estimated fair value. The current EPS without NRI is €-1.23. Sequana Medical NV's overall GF Score™ is 31/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Sequana Medical NV (FRA:2SE), the current EPS without NRI is €-1.23 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sequana Medical NV (FRA:2SE) Overvalued in 2026?

Based on GuruFocus' analysis, Sequana Medical NV stock appears to be overvalued. The current stock price of €0.51 is trading 169.5% above its estimated GF Value™ of €0.19.

Key valuation signals for FRA:2SE:

  • EPS without NRI: €-1.23
  • GF Value™: €0.19 vs. price of €0.51 (169.5% above fair value)
  • GF Score™: 31/100 with 12 warning signs

No single metric tells the full story. See the FRA:2SE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sequana Medical NV Business Description

Other Exchanges 2SE:GermanySEQUA:Belgium
Address Kortrijksesteenweg 1112, bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051
Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies. The company's geographical segments include Switzerland, Germany, the United Kingdom, France, and the Rest of the world, out of which Germany accounts for the majority of the revenue.
31GF Score

Get the complete analysis for FRA:2SE

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.51
Price
€0.19
GF Value